Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020

SELL
$6.53 - $10.72 $163,250 - $268,000
-25,000 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$6.16 - $9.6 $503,253 - $784,291
-81,697 Reduced 76.57%
25,000 $172,000
Q2 2019

Aug 08, 2019

BUY
$8.12 - $15.72 $139,412 - $269,896
17,169 Added 19.18%
106,697 $984,000
Q1 2019

Apr 30, 2019

SELL
$15.58 - $20.01 $1.17 Million - $1.5 Million
-75,156 Reduced 45.64%
89,528 $1.4 Million
Q4 2018

Jan 25, 2019

BUY
$14.59 - $23.84 $2.4 Million - $3.93 Million
164,684 New
164,684 $2.54 Million
Q1 2018

May 08, 2018

SELL
$16.68 - $22.07 $116,760 - $154,490
-7,000 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$11.23 - $19.1 $1,123 - $1,910
100 Added 1.45%
7,000 $133,000
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $106,329 - $221,973
6,900
6,900 $121,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cutler Capital Management, LLC Portfolio

Follow Cutler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Capital Management, LLC with notifications on news.